Omaxe Ltd

  • BSE Code : 532880
  • NSE Symbol : OMAXE
  • ISIN : INE800H01010
  • Industry :CONSTRUCTION

up-arrow 73.14 3.19(4.56%)

Open Price ()

68.20

Prev. Close ()

69.95

Volume (No’s)

133,670

Market Cap ()

1,337.73

Low Price ()

67.47

High Price ()

74.33

 

Board Meetings

Start Date End Date Purpose
30-Jan-2026 06-Feb-2026 Omaxe Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve The Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended on December 31 2025 and other matters. Please find enclosed a copy of intimation w.r.t. approval of Un-audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2025. Please find enclosed herewith copy of unaudited financial results for the quarter and nine months ended on December 31, 2025. (As Per BSE Announcement Dated on:06.02.2026)
07-Nov-2025 14-Nov-2025 Omaxe Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve the Unaudited Financial Results (Standalone & Consolidated) Of The Company for the quarter and half year ended On September 30 2025. Un-audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September 2025. (As Per BSE Announcement Dated on:14.11.2025)
06-Aug-2025 13-Aug-2025 Omaxe Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on June 30 2025 and other matters. Please find enclosed herewith the copy of Outcome of Meeting of Board of Directors held on August 13, 2025 (As Per BSE Announcement Dated on: 13.08.2025)
21-May-2025 28-May-2025 Quarterly Results & Audited Results Please find enclosed herewith copy of intimation w.r.t. to appointment of M/s S.K. Bhatt & Associates, Cost Auditors of the Company for the financial year 2025-26 (As per BSE Announcement Dated on 28/05/2025)
12-May-2025 15-May-2025 Fund Raising Inter alia, to consider the matter related to raising of funds, in one or more tranches, by way of issuance of securities and/or instruments, including but not limited to equity shares, convertible securities, non-convertible securities, or any combination thereof, through permissible modes such as private placement, preferential allotment, rights issue, qualified institutions placement, or any other method as may be deemed appropriate by the Board, subject to such statutory and regulatory approvals including approval of the shareholders of the Company as may be required, and to deliberate on such other business items as may be placed before the Board. Please find enclosed herewith the copy of intimation w.r.t. appointment of Independent Director. (As Per BSE Announcement Dated on: 15.05.2025)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew